Charles Remsberg - Rewalk Robotics Chief Officer
| RWLKDelisted Stock | USD 0.74 0.01 1.33% |
Executive
Charles Remsberg is Chief Officer of Rewalk Robotics
| Phone | 972 4 959 0123 |
| Web | https://www.rewalk.com |
Rewalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.1665) % which means that it has lost $0.1665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3424) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics' management efficiency ratios could be used to measure how well Rewalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities.Rewalk Robotics currently holds 897 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Rewalk Robotics has a current ratio of 21.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Rewalk Robotics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Lisa Wolf | Tivic Health Systems | 61 | |
| Stephanie Huebner | Vivos Therapeutics | N/A | |
| Ruth Hembree | Vivos Therapeutics | N/A | |
| Irene Thomas | Neuropace | 55 | |
| Leah Akin | Neuropace | N/A | |
| Kelley Nicholas | Neuropace | N/A | |
| Gordon Weber | SurModics | 61 | |
| Merav Dotan | Icecure Medical | 55 | |
| Matthew Link | Sight Sciences | 49 | |
| Adi Nir | Inspira Technologies Oxy | N/A | |
| Sean CPA | Rapid Micro Biosystems | 55 | |
| Indranil Dey | Bluejay Diagnostics | 61 | |
| John Manders | SurModics | 43 | |
| Tlalit TelTzure | Icecure Medical | 53 | |
| Robert Scott | Nuwellis | 43 | |
| Nicholas DeGennaro | Vivos Therapeutics | N/A | |
| Shmuel Gov | STRATA Skin Sciences | 64 | |
| Stephen JD | Sight Sciences | N/A | |
| Michael CFA | Rapid Micro Biosystems | N/A | |
| Amy Treadwell | Neuropace | N/A | |
| Daniella YeheskelyHayon | Inspira Technologies Oxy | 47 | |
Management Performance
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 |
Rewalk Robotics Leadership Team
Elected by the shareholders, the Rewalk Robotics' board of directors comprises two types of representatives: Rewalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rewalk. The board's role is to monitor Rewalk Robotics' management team and ensure that shareholders' interests are well served. Rewalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rewalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Director | ||
| Michael Lawless, Chief Officer | ||
| David Hexner, VP RD | ||
| Ami Kraft, Ex CEO | ||
| Miri Pariente, Global Director - Quality | ||
| Jeannine Lynch, Vice Strategy | ||
| Kathleen ODonnell, Vice Development | ||
| Judy Kula, Human Service | ||
| Charles Remsberg, Chief Officer |
Rewalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rewalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.38) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 28.94 M | |||
| Shares Outstanding | 60.02 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 20.71 % | |||
| Number Of Shares Shorted | 1.36 M | |||
| Price To Earning | (0.77) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |